An EU health policy for rheumatic and musculoskeletal diseases

Rheumatic and musculoskeletal diseases (RMDs) represent one of the more burdensome chronic diseases affecting around 25% of EU citizens of all ages. [Shutterstock]

Rheumatic and musculoskeletal diseases (RMDs) represent one of the more burdensome chronic diseases affecting around 25% of EU citizens of all ages.

The European League Against Rheumatism (Eular) says that, beyond the impact on individuals, RMDs impose an enormous burden on European societies, particularly in terms of productivity loss, as well as in terms of health care and social security costs.

“In order to address the enormous health and financial challenges imposed by RMDs and other chronic conditions, it is imperative that the EU and European countries further commit to finding effective, comprehensive solutions,” Eular recently said.

In this Event Report, EURACTIV will analyse how can we achieve a sustainable and effective EU health policy for citizens, focusing on chronic diseases and inclusion in social and economic life.

Download PDF  

Subscribe to our newsletters

Subscribe

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.